$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Method and formulation of stimulating nitric oxide synthesis 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/195
출원번호 US-0321051 (1994-10-05)
발명자 / 주소
  • Kaesemeyer W. H. (2433 McDowell St. August GA 30904)
인용정보 피인용 횟수 : 78  인용 특허 : 0

초록

A therapeutic mixture comprising a mixture of L-arginine and an agonist of nitric oxide synthase, namely nitroglycerin, is disclosed for the treatment of diseases related to vasoconstriction, wherein the vasoconstriction is relieved by stimulating the constitutive form of nitric oxide synthase (cNOS

대표청구항

A method of treating a disease condition in a subject by vasodilation or vasorelaxation comprising: selecting a subject; mixing L-arginine and a venous dilator, said venous dilator being different than L-arginine; administering to said subject a formulation comprising said mixture; obtaining periodi

이 특허를 인용한 특허 (78)

  1. Kramer, Ronald; Nikolaidis, Alexander, Amino acid compositions.
  2. Kramer, Ronald; Nikolaidis, Alexander, Amino acid compositions.
  3. Kramer, Ronald; Nikolaidis, Alexander, Amino acid compositions.
  4. Kramer, Ronald; Nikolaidis, Alexander, Amino acid compositions.
  5. Kramer, Ronald; Nikolaidis, Alexander, Amino acid compositions.
  6. Fossel, Eric T., Beneficial effects of increasing local blood flow.
  7. Kramer, Ronald; Nikolaidis, Alexander, Betaine compounds.
  8. Kealey, Kirk S.; Snyder, Rodney M.; Romanczyk, Jr., Leo J.; Geyer, Hans M.; Myers, Mary E.; Whitacre, Eric J.; Hammerstone, Jr., John F.; Schmitz, Harold H., Chocolates and chocolate liquor having an enhanced polyphenol content.
  9. Berkson, Lindsey; Burton, Kenneth G., Composition for treating a dermal anomaly.
  10. Berkson, Lindsey; Burton, Kenneth G., Composition for treating a dermal anomaly.
  11. Garvey David S. ; Schroeder Joseph D. ; Saenz de Tejada Inigo,ESX, Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use.
  12. Rothbard, Jonathan B.; McGrane, Paul L.; Engleman, Edgar G.; Fathman, C. Garrison; Kreider, Erik, Compositions and methods for treating diseases.
  13. Garvey David S. ; Schroeder Joseph D. ; de Tejada Inigo Saenz,ESX, Compositions and methods for treating sexual dysfunctions.
  14. Fossel, Eric T., Delivery of ibuprofen and other compounds.
  15. Fossel, Eric T., Delivery of ibuprofen and other compounds.
  16. Fossel, Eric T., Delivery of ibuprofen and other compounds.
  17. Cooke John P. ; Dzau Victor J. ; Gibbons Gary H., Enhancement of vascular function by modulation of endogenous nitric oxide production or activity.
  18. Cooke, John P.; Dzau, Victor J.; Gibbons, Gary H., Enhancement of vascular function by modulation of endogenous nitric oxide production or activity.
  19. Cooke,John P., Enhancement of vascular function by modulation of endogenous nitric oxide production or activity.
  20. Chevaux, Kati A.; Schmitz, Harold H.; Romanczyk, Jr., Leo J., Food products containing polyphenol(s) and L-arginine to stimulate nitric oxide.
  21. Kaesemeyer Wayne H., Formulations for treating disease and methods of using same.
  22. Garvey, David S.; Schroeder, Joseph D.; Saenz de Tejada, Inigo, Imidazoline .alpha.-adrenergic receptor antagonist compounds in combination with nitric oxide donors, compositions and methods of use.
  23. Moskowitz, Michael A.; Liao, James K.; Ron, Eyal S.; Omstead, Mary Nallin, Increasing cerebral bioavailability of drugs.
  24. Cooke John P. ; Schwarzacher Sverin ; Lim Tai T.,SGX ; Yeung Alan C., Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury.
  25. Aileen Sontag Trant, Method and composition for improving fertility health in female and male animals and humans.
  26. Trant,Aileen Sontag, Method and composition for improving fertility health in female and male animals and humans.
  27. Trant,Aileen Sontag, Method and composition for improving male fertility health.
  28. Hank C. K. Wuh ; Aileen S. Trant ; Denny W. Kwock, Method and composition for improving sexual fitness.
  29. Wuh, Hank C. K.; Trant, Aileen S., Method and composition for improving sexual fitness.
  30. Wuh,Hank C. K.; Trant,Aileen S., Method and composition for improving sexual fitness.
  31. Kaesemeyer Wayne H., Method and formulation for treating vascular disease.
  32. Wayne H. Kaesemeyer, Method of stimulating nitric oxide synthase.
  33. David S. Garvey ; Inigo Saenz de Tejada ES, Methods for treating female sexual dysfunctions.
  34. Romanczyk, Jr., Leo J.; Schmitz, Harold H., Methods of manufacture and combination compositions.
  35. Michael P. Vitek ; Carol A. Colton, Modulation of nitric oxide production.
  36. Jeffrey E. Thomas, Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal.
  37. David S. Garvey ; Joseph D. Schroeder ; Inigo Saenz de Tejada ES, Nitrosated and nitrosylated .alpha.-adrenergic receptor antagonist compounds, compositions and their uses.
  38. David S. Garvey ; Joseph D. Schroeder ; Inigo Saenz de Tejada ES, Nitrosated and nitrosylated .alpha.-adrenergic receptor antagonist compounds, compositions and their uses.
  39. David S. Garvey ; Joseph D. Schroeder ; Inigo Saenez de Tejada ES; Ricky D. Gaston ; Tatiana E. Shelekhin ; Tiansheng Wang, Nitrosated and nitrosylated .alpha.-adrenergic receptor antagonist, compositions and methods of use.
  40. Garvey David S. ; Saenz de Tejada Inigo,ESX, Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses.
  41. Garvey David S. ; Saenz de Tejada Inigo,ESX, Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses.
  42. Garvey David S. ; Saenz de Tejada Inigo,ESX, Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses.
  43. Garvey David S. ; Saenz de Tejada Inigo,ESX, Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses.
  44. Garvey David S. ; Saenz de Tejada Inigo,ESX, Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses.
  45. Garvey David S. ; de Tejada Inigo Saenz,ESX, Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses.
  46. Garvey David S. ; de Tejada Inigo Saenz,ESX, Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses.
  47. Garvey David S. ; de Tejada Inigo Saenz,ESX, Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses.
  48. Garvey David S. ; de Tejada Inigo Saenz,ESX, Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses.
  49. Garvey David S. ; de Tejada Inigo Saenz,ESX, Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses.
  50. Garvey David S. ; de Tejada Inigo Saenz,ESX, Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses.
  51. David S. Garvey ; Inigo Saenz de Tejada ES; Richard A. Earl ; Subhash P. Khanapure, Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use.
  52. Garvey David S. ; de Tejada Inigo Saenz,ESX ; Earl Richard A. ; Khanapure Subhash P., Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use.
  53. Garvey, David S.; de Tejada, Inigo Saenz; Earl, Richard A.; Khanapure, Subhash P., Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use.
  54. Garvey David S. ; Saenz de Tejada Inigo,ESX, Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses.
  55. Stamler, Jonathan S.; Gow, Andrew J., No-modified hemoglobins and uses therefor.
  56. Stamler, Jonathan S., No-modified hemoglobins and uses therefore.
  57. Kaesemeyer,Wayne H., Pharmaceutical composition comprising citrulline.
  58. Gross, Steven S.; Jones, Caroline L., Pharmacotherapy for vascular dysfunction associated with deficient nitric oxide bioactivity.
  59. Chevaux, Kati A.; Schmitz, Harold H.; Romanczyk, Leo J., Products containing polyphenol(s) and L-arginine.
  60. Chevaux, Kati A.; Schmitz, Harold H.; Romanczyk, Leo J., Products containing polyphenol(s) and L-arginine and methods of use thereof.
  61. Fossel, Eric T., Systems and methods for treatment of allergies and other indications.
  62. Wayne H. Kaesemeyer, Therapeutic mixture useful in inhibiting lesion formation after vascular injury.
  63. Fossel, Eric T., Topical composition containing ibuprofen.
  64. Fossel, Eric T., Topical composition containing naproxen.
  65. Barone, Jr.,Frank V.; Jacobsen,Christopher; Chumenko,Kirill, Topical compositions for enhancing sexual responsiveness.
  66. Fossel, Eric T., Topical delivery of L-arginine to cause beneficial effects.
  67. Fossel, Eric T., Topical delivery of L-arginine to cause beneficial effects.
  68. Fossel, Eric Thor, Transdermal delivery of beneficial substances effected by a hostile biophysical environment.
  69. Fossel, Eric T., Treatment of erectile dysfunction and other indications.
  70. Fossel, Eric T., Treatment of erectile dysfunction and other indications.
  71. Fossel, Eric T., Treatment of erectile dysfunction and other indications.
  72. Fossel, Eric T., Treatment of erectile dysfunction and other indications.
  73. Fossel, Eric T., Treatment of erectile dysfunction and other indications.
  74. Fossel, Eric T., Treatment of erectile dysfunction and other indications.
  75. Fossel, Eric T., Treatment of erectile dysfunction and other indications.
  76. Cooke John P. ; Dzau Victor J. ; Gibbons Gary H., Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity.
  77. Liao James K. ; Laufs Ulrich,DEX ; Endres Matthias,DEX ; Moskowitz Michael A., Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors.
  78. Liao James K., Upregulation of Type III endothelial cell nitric oxide synthase by rho GTPase function inhibitors.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로